![]()
|
|
||||||||
J. Biol. Chem., Vol. 282, Issue 7, 4310-4317, February 16, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Molecular Biology, Helen L. Dorris Institute for Neurological and Psychiatric Disorders, The Scripps Research Institute, La Jolla, California 92037
Lysophosphatidic acid (LPA) is a bioactive lysophospholipid that signals through G protein-coupled receptors (GPCRs) to produce a range of biological responses. A recently reported fourth receptor, LPA4/GPR23, was notable for its low homology to the previously identified receptors LPA13 and for its ability to increase intracellular concentrations of cAMP and calcium. However, the signaling pathways leading to LPA4-mediated induction of cAMP and calcium levels have not been reported. Using epitope-tagged LPA4, pharmacological intervention, and G protein mini-genes, we provide independent confirmatory evidence that supports LPA4 as a fourth LPA receptor, including LPA concentration-dependent responses and specific membrane binding. Importantly, we further demonstrate new LPA-dependent activities of LPA4 that include the following: receptor internalization; G12/13- and Rho-mediated neurite retraction and stress fiber formation; Gq protein and pertussis toxin-sensitive calcium mobilization and activation of a nonselective cation conductance; and cAMP increases mediated by Gs. The receptor is broadly expressed in embryonic tissues, including brain, as determined by Northern blot and reverse transcription-PCR analysis. Adult tissues have increased expression in skin, heart, and to a lesser extent, thymus. These data confirm the identification and extend the functionality of LPA4 as an LPA receptor, bringing the number of independently verified LPA receptors to five, with both overlapping and distinct signaling properties and tissue expression.
Received for publication, November 22, 2006
* This work was supported by National Institute of Mental Health Grants K02-MH01723 and R01-MH51699 and NINDS Grant R01-NS048478 and NICHD Grant R01-050685 from the National Institutes of Health (to J. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Dept. of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Rd., ICND-118, La Jolla, CA 92037. Tel.: 858-784-8410; Fax: 858-784-7084; E-mail: jchun{at}scripps.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
V. E. Miron, J. A. Hall, T. E. Kennedy, B. Soliven, and J. P. Antel Cyclical and Dose-Dependent Responses of Adult Human Mature Oligodendrocytes to Fingolimod Am. J. Pathol., October 1, 2008; 173(4): 1143 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ye Lysophospholipid signaling in the function and pathology of the reproductive system Hum. Reprod. Update, September 1, 2008; 14(5): 519 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ye, M. K. Skinner, G. Kennedy, and J. Chun Age-Dependent Loss of Sperm Production in Mice via Impaired Lysophosphatidic Acid Signaling Biol Reprod, August 1, 2008; 79(2): 328 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dottori, J. Leung, A. M. Turnley, and A. Pebay Lysophosphatidic Acid Inhibits Neuronal Differentiation of Neural Stem/Progenitor Cells Derived from Human Embryonic Stem Cells Stem Cells, May 1, 2008; 26(5): 1146 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Ptaszynska, M. L. Pendrak, R. W. Bandle, M. L. Stracke, and D. D. Roberts Positive Feedback between Vascular Endothelial Growth Factor-A and Autotaxin in Ovarian Cancer Cells Mol. Cancer Res., March 1, 2008; 6(3): 352 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Pamuklar, J. S. Lee, H.-Y. Cheng, M. Panchatcharam, S. Steinhubl, A. J. Morris, R. Charnigo, and S. S. Smyth Individual Heterogeneity in Platelet Response to Lysophosphatidic Acid: Evidence for a Novel Inhibitory Pathway Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 555 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Murph, J. Hurst-Kennedy, V. Newton, D. N. Brindley, and H. Radhakrishna Lysophosphatidic Acid Decreases the Nuclear Localization and Cellular Abundance of the p53 Tumor Suppressor in A549 Lung Carcinoma Cells Mol. Cancer Res., November 1, 2007; 5(11): 1201 - 1211. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |